These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12896854)

  • 1. Neurologic outcomes of toxic oil syndrome patients 18 years after the epidemic.
    de la Paz MP; Philen RM; Gerr F; Letz R; Ferrari Arroyo MJ; Vela L; Izquierdo M; Arribas CM; Borda IA; Ramos A; Mora C; Matesanz G; Roldán MT; Pareja J
    Environ Health Perspect; 2003 Aug; 111(10):1326-34. PubMed ID: 12896854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic oil syndrome: the perspective after 20 years.
    Posada de la Paz M; Philen RM; Borda AI
    Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
    Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
    Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
    Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life, disability and handicap in patients with toxic oil syndrome.
    Martín-Arribas MC; De Andrés Copa P; De La Paz MP
    J Adv Nurs; 2005 Jun; 50(6):595-604. PubMed ID: 15926964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
    Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufacturing processes at two French rapeseed oil companies: possible relationships to toxic oil syndrome in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Bernert JT; Gancedo JC; DuClos PJ; Kilbourne EM
    Food Chem Toxicol; 1991 Dec; 29(12):797-803. PubMed ID: 1765323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla.
    Posada M; Castro M; Kilbourne EM; Diaz de Rojas F; Abaitua I; Tabuenca JM; Vioque A
    Food Chem Toxicol; 1987 Jan; 25(1):87-90. PubMed ID: 3817664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome.
    Posada de la Paz M; Philen RM; Schurz H; Hill RH; Giménez Ribota O; Gómez de la Camara A; Kilbourne EM; Abaitua I
    Epidemiology; 1999 Mar; 10(2):130-4. PubMed ID: 10069247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience.
    Stokes L; Letz R; Gerr F; Kolczak M; McNeill FE; Chettle DR; Kaye WE
    Occup Environ Med; 1998 Aug; 55(8):507-16. PubMed ID: 9849536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic oil syndrome: survival in the whole cohort between 1981 and 1995.
    Sánchez-Porro Valadés P; Posada de la Paz M; de Andrés Copa P; Gimenez Ribota O; Abaitua Borda I
    J Clin Epidemiol; 2003 Jul; 56(7):701-8. PubMed ID: 12921940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of toxic oil syndrome on the psychological conditions of the descendants of affected persons.
    Almansa A; Borda IA; Abaitua MA; Banegas JR
    Epidemiol Prev; 2008; 32(4-5):212-7. PubMed ID: 19186503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The limits of epidemiology and the Spanish Toxic Oil Syndrome.
    Terracini B
    Int J Epidemiol; 2004 Jun; 33(3):443-4. PubMed ID: 15166211
    [No Abstract]   [Full Text] [Related]  

  • 14. The association of oil ingestion with toxic oil syndrome in two convents.
    Diaz de Rojas F; Castro García M; Abaitua Borda I; Alonso Gordo JM; Posada de la Paz M; Kilbourne EM; Tabuenca Oliver JM
    Am J Epidemiol; 1987 May; 125(5):907-11. PubMed ID: 3565366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
    Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
    J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism.
    del Pozo V; de Andrés B; Gallardo S; Cárdaba B; de Arruda-Chaves E; Cortegano MI; Jurado A; Palomino P; Oliva H; Aguilera B; Posada M; Lahoz C
    Toxicology; 1997 Mar; 118(1):61-70. PubMed ID: 9074654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
    Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
    Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spanish toxic oil syndrome: ten years after the disaster.
    Ortega-Benito JM
    Public Health; 1992 Jan; 106(1):3-9. PubMed ID: 1603915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
    Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
    Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
    Maitani T; Saitoh H
    Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.